Skip to content
Peptide Field Notes
All peptides

Metabolic / fat loss

5-Amino-1MQ Dosage: Mouse Data, Human Hopes

A clever fat-loss mechanism with strong mouse data and zero human trials.

Kenny5-Amino-1MQLast reviewed June 2026

The quick version

  • A small molecule that blocks NNMT to push fat-burning.
  • Good mouse data, zero human trials. Dosing and safety are unknown.
  • Promising on paper, unproven in people.

What it is

5-Amino-1MQ is a small molecule that blocks an enzyme called NNMT, which is busy in fat tissue. Blocking it is meant to push cells to burn fat instead of store it.

What the research shows

The mechanism is interesting and the animal data is encouraging: in obese mice it reversed weight gain and improved glucose handling, and it raised NAD+ in fat cells. The catch is simple. There are no published human trials. Everything is mice and cell dishes, so human dosing and safety are unknown.

What it felt like

I have not run 5-Amino-1MQ. With no human data at all, I would rather watch than be the experiment, and I would say the same to a friend.

Dosing reality

Sellers float oral doses around 50 to 150 mg per day, but those numbers are extrapolated from mice, not tested in people. Treat any human dose as a guess.

The one mistake to avoid

The mistake is reading strong mouse results as a sure thing. Plenty of compounds shine in mice and do nothing in humans, and this one has not been tried yet.

Bottom line

5-Amino-1MQ has a clever mechanism and good mouse data, but zero human evidence. Promising on paper, unproven in people.

Reminder: I am not a doctor and this is not medical advice. It is my own notes and reading of the research. Peptides sit in a legal grey area, research-grade is a real category, and it is on you to verify your own compliance. Talk to a qualified professional before you start anything, especially if you take other medication.